Skip to content

Insider · CIK 0001559112

Kathy J Warden

directorceopresidentchairofficer

Files at MRK (Merck & Co., Inc.), NOC (NORTHROP GRUMMAN CORP /DE/). First filing Jun 13, 2025, latest Feb 10, 2026.

In brief

Kathy J Warden files SEC Form 4 as director, CEO, president and chair at NOC (NORTHROP GRUMMAN CORP /DE/), and also at MRK (Merck & Co., Inc.). Since Jun 13, 2025, Kathy J Warden has reported 0 open-market buys worth $0 and 3 open-market sells worth $26M, the latest filed on Feb 10, 2026.

A track record needs three past buys with six months of prices behind them; Kathy J Warden has 0, so none is measured yet.

The newest scored trade: sold $14M of NOC on Feb 6, 2026, filed Feb 10, 2026, scored 70 (notable). In the last 12 months: 0 buys worth $0 and 2 sells worth $20M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $26M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

NOC: NORTHROP GRUMMAN CORP /DE/

NOCOct 9, 2026 · close 480.72

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
70Notable
NOCsell 6
NORTHROP GRUMMAN CORP /DE/
$14M
20,000 shares
-10%+66% from low0% from high
30Weak
NOCsell10b5-1
NORTHROP GRUMMAN CORP /DE/
$6.0M
10,000 shares
-5%+43% from low-4% from high
45Moderate
NOCsell 510b5-1
NORTHROP GRUMMAN CORP /DE/
$5.6M
11,250 shares
-5%+16% from low-8% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Feb 6, 2026 NOC
NORTHROP GRUMMAN CORP /DE/
20,000
0.01% of outstanding
$14MFeb 6, 2026$6.0M
Jan 6, 2026 NOC
NORTHROP GRUMMAN CORP /DE/
3,000
0.00% of outstanding
$1.8MJan 6, 2026$4.2M
Jan 5, 2026 NOC
NORTHROP GRUMMAN CORP /DE/
7,000
0.00% of outstanding
$4.2MJan 5, 2026none
Jun 13, 2025 NOC
NORTHROP GRUMMAN CORP /DE/
7,500
0.01% of outstanding
$3.8MJun 13, 2025$1.9M
Jun 12, 2025 NOC
NORTHROP GRUMMAN CORP /DE/
3,750
0.00% of outstanding
$1.9MJun 12, 2025none
Mar 6, 2025 NOC
NORTHROP GRUMMAN CORP /DE/
3,750
0.00% of outstanding
$1.8MMar 6, 2025none

Transactions

Every row this insider has filed, 22 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 19, 2026NOC
NORTHROP GRUMMAN CORP /DE/
AGrant or award
Market Stock Unitsderivative
+35,910$0.00$035,910Aug 21, 2026
May 29, 2026MRK
Merck & Co., Inc.
AGrant or award
Phantom Stockderivative
+1,853$118.72$220k17,890Jun 2, 2026
Feb 17, 2026NOC
NORTHROP GRUMMAN CORP /DE/
MOption exercise
Common Stock
+10,760$0.00$0201,538Feb 19, 2026
Feb 17, 2026NOC
NORTHROP GRUMMAN CORP /DE/
FTax withholding
Common Stock
-4,857$701.12$3.4M196,681Feb 19, 2026
Feb 17, 2026NOC
NORTHROP GRUMMAN CORP /DE/
MOption exercise
Restricted Stock Rightsderivative
-10,760$0.00$031,020Feb 19, 2026
Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
MOption exercise
Common Stock
+34,546$0.00$0206,149Feb 13, 2026
Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
FTax withholding
Common Stock
-15,371$678.83$10M190,778Feb 13, 2026
Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
AGrant or award
Restricted Performance Stock Rightsderivative
+28,785$0.00$0102,064Feb 13, 2026
Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
AGrant or award
Restricted Stock Rightsderivative
+8,113$0.00$041,780Feb 13, 2026
Feb 11, 2026NOC
NORTHROP GRUMMAN CORP /DE/
MOption exercise
Restricted Performance Stock Rightsderivative
-34,546$0.00$067,518Feb 13, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-214$705.84$151k191,388Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-2,196$706.65$1.6M189,192Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-4,695$707.45$3.3M184,497Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-2,303$708.63$1.6M182,194Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-5,734$709.49$4.1M176,460Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-3,552$710.36$2.5M172,908Feb 10, 2026
Feb 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock
-1,306$711.14$929k171,602Feb 10, 2026
Jan 5, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock10b5-1
-7,000$600.00$4.2M194,602Jan 7, 2026
Jan 6, 2026NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock10b5-1
-3,000$615.00$1.8M191,602Jan 7, 2026
Jun 12, 2025NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock10b5-1
-3,750$495.00$1.9M209,102Jun 13, 2025
Jun 13, 2025NOC
NORTHROP GRUMMAN CORP /DE/
SOpen-market sale
Common Stock10b5-1
-7,500$505.77$3.8M201,602Jun 13, 2025
May 30, 2025MRK
Merck & Co., Inc.
AGrant or award
Phantom Stockderivative
+2,863$76.84$220k15,504Jun 3, 2025

Questions about Kathy J Warden

Answered from the filings on this page, as of the latest one.

Is Kathy J Warden buying or selling?

In the last 12 months Kathy J Warden reported 0 open-market buys worth $0 and 2 open-market sells worth $20M on SEC Form 4; the latest was sold $14M of NOC on Feb 6, 2026. Grants, option exercises and tax withholding are not counted.

How did Kathy J Warden's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kathy J Warden has 0.

Where does Kathy J Warden file Form 4?

Kathy J Warden has filed Form 4 at NOC (NORTHROP GRUMMAN CORP /DE/) as Chair, CEO and President; MRK (Merck & Co., Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kathy J Warden: insider trades and track record | InsiderTell